(Q38442625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Mar Tintoré

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Ferran Torres

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Xavier Montalban

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Eva Martínez-Cáceres

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

L Grau-López

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

A Rovira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Ramió i Torrenta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Brieva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

A Cano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

O Carmona

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

A Saiz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

P Giner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

C Nos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

A Massuet

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J Costa

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

21 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

717-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24144876%20AND%20SRC:MED&resulttype=core&format=json

Disease activity and emotional state in multiple sclerosis.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Multiple sclerosis: diagnosis and the management of acute relapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Patient preferences for oral versus intravenous palliative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Cost of managing an episode of relapse in multiple sclerosis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835

Are Intravenous Corticosteroids Required in Status Asthmaticus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458513508835